Why Memory Loss Is Being Missed by Doctors‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎
‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎
‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎
‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎
‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎
‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎
‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎
‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎
‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎
‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎
‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎
‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎



<[link removed]>

September 27


 

 





ONE COMMON PILL CAN MIMIC ALZHEIMER’S.
Most people assume memory loss
<[link removed]>
is just a normal part of getting older.

But doctors are now discovering something disturbing:

One of 9 very common prescription drugs may be silently damaging the brain.
<[link removed]>

It can mimic Alzheimer’s disease almost perfectly.
<[link removed]>

And it’s leading to widespread misdiagnosis across America.
<[link removed]>

If you’re over 45
<[link removed]>
and take any prescription medication, this deserves your attention.

Because thousands of Americans are being told they have Alzheimer’s…

When the real cause is sitting in their medicine cabinet.
<[link removed]>

Medical researchers now call this condition drug-induced dementia.
<[link removed]>

And once it begins, everything looks the same as Alzheimer’s:
memory loss, confusion, personality changes.

>> Spouses don’t question it.
<[link removed]>
>> Children don’t question it.
<[link removed]>
>> Even doctors don’t question it.
<[link removed]>

Unless someone knows what to look for.


According to new data, more than 1,429,000 American seniors could be affected
this year alone.
See the full list of the 9 drugs linked to Alzheimer’s
<[link removed]>

If you or your spouse are taking even one of these medications, your memory
could already be at risk.

Review the list here before it’s dismissed as “aging”
<[link removed]>
— Harvard Neurologist


P.S.
Doctors are misdiagnosing this across America — and families are paying the
price.
Click here to see the 9 common prescriptions involved
<[link removed]>

If you'd rather not receive these emails, you can unsubscribe here
<[link removed]>
.


 





CONNOR'S HEALTH NOTES
Some Cognitive Decline Has a Reversible Cause
Medication is one of the first things a proper memory evaluation looks at,
which is why the useful step is a review with the prescriber rather than a list
of drugs to fear. Connor Hill · InsightfulWord · September 26, 2026
The claim that medicines can impair thinking in older adults is not fringe. It
is standard geriatric medicine, it has its own published criteria, and it is
one of the first things a competent memory evaluation examines.

Before anything else, the presentation that does not wait. Confusion that
develops over hours or days, with fluctuating alertness, is delirium rather
than dementia, and it is a medical emergency — commonly caused by infection,
dehydration, a new medication or withdrawal from one. Sudden weakness on one
side, facial droop, difficulty speaking or a sudden severe headache require
emergency care immediately.

And the standing rule matters more here than almost anywhere else: no medicine
on any list should be stopped or reduced without the prescriber. Several drugs
with cognitive effects are taken for serious conditions, and abrupt withdrawal
of some of them causes seizures, rebound symptoms or worse.

With those set aside, the underlying medicine is well established. Drugs with
anticholinergic activity block a neurotransmitter used throughout the brain in
attention and memory, and the effect is dose-related, cumulative across several
products, and largely reversible when the burden is reduced.

Sedatives of the benzodiazepine class and their newer relatives act
differently but produce overlapping symptoms, particularly in older adults
whose clearance is slower.

Professional bodies maintain explicit lists. Criteria published and updated by
a geriatrics society name medications that are potentially inappropriate in
older adults, with the reason and the strength of evidence for each, and
clinicians and pharmacists use them routinely.

What none of this supports is the frightening version. A drug that impairs
attention and memory is not causing Alzheimer's disease, and reversible
impairment from medication is diagnosed by improvement after withdrawal rather
than by a list.

The genuinely useful conclusion is procedural. Anyone concerned about memory
should arrive at an appointment with a complete medication list, because that
is the part of the evaluation most likely to yield something fixable.

What this piece checks
What anticholinergic and sedative medicines do to attention and memory, and
why burden adds up
The published criteria clinicians use, and what they do and do not say
The reversible causes a proper memory workup excludes before anything else
What the Drugs Actually Do

The mechanism is specific, which is what makes the effect predictable rather
than mysterious.

Acetylcholine is a neurotransmitter central to attention, learning and
short-term memory. Drugs that block its receptors reduce those functions in
proportion to how much blockade they produce.

Many medicines have anticholinergic activity as a side effect rather than a
purpose: older antihistamines, some antidepressants, drugs for overactive
bladder, several for nausea and vertigo, and some muscle relaxants.

Burden is cumulative. Scales exist that score individual drugs for
anticholinergic activity and sum them across a person's list, and a total at or
above a commonly used threshold of three is treated as clinically significant.

Peripheral effects arrive with the central ones and are easier to notice: dry
mouth, constipation, blurred vision, urinary retention and a faster heart rate.
Where several of those appear together, the burden is usually worth checking
whatever the memory complaint.

Older adults are more affected for several reasons at once: reduced clearance,
a more permeable blood-brain barrier, less cholinergic reserve, and more
medicines taken simultaneously.

Sedative-hypnotics act on a different receptor system and produce daytime
drowsiness, slowed processing and unsteadiness, with falls as the most serious
consequence.

Timing of doses matters alongside the choice of drug. A sedating product taken
in the evening can leave measurable impairment the following morning in an
older person, and shifting the time or the formulation sometimes resolves the
complaint without changing the medicine at all.

The distinguishing feature of all of this is reversibility. Where medication
is the cause, function improves after the drug is reduced or replaced, usually
over weeks — which is a test rather than a theory.

The Lists Clinicians Use

Explicit criteria exist precisely so that this is not a matter of individual
opinion.

🩺 Clinical Signal Three or more
A commonly used threshold on anticholinergic burden scales, which score each
medication for anticholinergic activity and sum the scores across a person's
list; totals at or above three are generally treated as clinically significant
in older adults. Separately, the American Geriatrics Society publishes and
periodically updates explicit criteria identifying medications that are
potentially inappropriate in older adults, with the rationale and strength of
evidence stated for each entry. Source: American Geriatrics Society, 2023
updated AGS Beers Criteria.

Support or oppose: should pharmacies flag cumulative anticholinergic burden at
the counter?
Supporters argue that no single prescriber sees the whole list, that the
calculation is trivial for a system that already holds every dispensed item,
and that a flag at the point of dispensing reaches the person who can act.
Opponents answer that alerts are already ignored at scale, that many of these
drugs are appropriate despite the burden, and that a warning without a
clinician to interpret it produces anxiety and unsupervised stopping. Which is
better?

Hit reply — one line is enough.

The criteria are organized by category: medicines to avoid in most older
adults, medicines to avoid with specific conditions, medicines requiring
caution, and interactions to avoid.

The evidence behind individual entries varies, and the criteria say so. Some
rest on randomized data, others on observational studies and expert consensus,
and the document grades each rather than presenting a flat list.

They are explicitly not a prohibition. Each entry states a rationale and a
recommendation, and clinical judgment can properly override any of them for an
individual.

Anticholinergic burden scales are separate instruments, several of them exist,
and they disagree at the margins about which drugs score what — which is a
reason to treat a total as a prompt rather than a verdict.

Prescribing cascades are the other pattern these reviews look for: a side
effect of one drug treated with a second drug, whose own side effects are
treated with a third. Identifying the original link frequently removes two
medicines rather than one.

Over-the-counter products are where most of the unrecognized burden sits,
because they are bought without a consultation and are frequently absent from
the medication list a clinician sees.

The practical use of all of it is the same: a structured review that produces
a decision for each item — continue, reduce, replace or stop, with a plan and a
follow-up date.

What a Proper Workup Excludes First

Memory complaints have a standard evaluation, and reversible causes sit near
the front of it.

Worth stating plainly — what a list of drugs establishes
A list of medications associated with cognitive effects establishes that those
effects have been observed and studied. It does not establish that any
individual's symptoms are caused by a drug they take, how large the effect is
for them, or that stopping is safe or appropriate. Association in observational
studies is not the same as causation, and the people prescribed these medicines
differ from those who are not in ways that are difficult to adjust for fully.
Nothing here is advice to start, stop or change any medication; those decisions
belong with the prescriber.

Blood tests come first and are cheap: thyroid function and vitamin B12 are the
classic reversible causes, alongside metabolic and kidney measures.

Depression is next and is frequently mistaken for dementia in older adults,
producing poor concentration, slowed thinking and apparent memory failure that
resolves with treatment.

Sleep disorders follow. Obstructive sleep apnea impairs attention and memory
and is both common and treatable, and it is missed unless someone asks.

Pain and its treatment sit in the same conversation. Untreated pain impairs
concentration and sleep, while some of the drugs used to treat it impair
cognition directly, which makes it one of the harder trade-offs in the whole
review.

Alcohol use is asked about explicitly, because it is a leading contributor and
is under-reported in every age group.

Hearing and vision are checked in the same visit and are among the most
under-appreciated contributors. Someone who cannot hear a question reliably
performs poorly on a verbal memory test for reasons that have nothing to do
with memory.

Imaging of the brain is used to exclude structural causes, and cognitive
testing establishes a baseline against which any change after an intervention
can be measured.

Only after that sequence does a diagnosis of a progressive dementia become
appropriate, and the sequence exists because each earlier step can produce the
same picture.

How Deprescribing Is Actually Done

Reducing a medication list is a clinical procedure with its own evidence base,
not an act of subtraction.

The first step is a complete inventory: every prescription, every
over-the-counter product, every supplement, with doses and who prescribed them.

Each item is then assessed against current goals. A drug started for a
condition that resolved, or one whose benefit is long-term while the person's
horizon is short, is a candidate.

Tapering is planned rather than abrupt for anything with withdrawal risk, and
several classes — sedatives among them — require slow reduction over weeks to
months.

One change at a time is the rule, with a defined interval before the next, so
that any effect can be attributed.

Informants matter throughout. A family member's account of function at home —
managing money, medications, appointments — is more informative than any single
office test, and clinicians ask for it explicitly where consent allows.

Monitoring closes the loop. Symptoms, cognition and function are checked at
the follow-up, and a change that made things worse is reversed rather than
endured.

The short checklist
1 Bring every container to the appointment, including over-the-counter
products, sleep aids and supplements, rather than a remembered list.
2 Ask directly whether anything on the list carries anticholinergic or
sedative burden, and what the alternatives are.
3 Ask for the standard reversible-cause tests: thyroid, B12, metabolic panel,
and a discussion of mood and sleep.
4 Request a documented baseline cognitive assessment, so that any later change
is measured rather than recalled.
5 Change one medicine at a time, with a written plan, a taper where needed and
a follow-up date.
6 Treat sudden confusion over hours or days as an emergency rather than as
progression.
The scale of the problem is worth stating in proportion. Reviews consistently
find that a meaningful minority of older adults take at least one medicine
flagged by the published criteria, which is large enough to matter and far from
an epidemic of misdiagnosis.

Documentation closes the loop for the family as much as for the clinician. A
written note of what was changed, when and why travels with the person to the
next appointment, which matters most where several prescribers are involved and
none of them sees the whole list.

The composite point is that medication effects on cognition are established,
cumulative and reversible, that published criteria and burden scales exist to
identify them, and that the step which actually helps is a structured review
with the prescriber rather than a list of drugs to be frightened of.

The bill, not the debate
Anticholinergic burden adds up across products, with a total of three or more
generally treated as significant, and much of it comes from over-the-counter
medicines nobody lists. Published criteria name potentially inappropriate
medicines in older adults with reasons attached. Reversible causes — thyroid,
B12, depression, sleep, alcohol — are excluded before any dementia diagnosis.
When a list of drugs is put in front of you, has anyone reviewed the actual
list in your cabinet?

Connor Hill reads every reply.
Sources checked Verified September 26, 2026
American Geriatrics Society — 2023 updated AGS Beers Criteria for potentially
inappropriate medication use in older adults —
[link removed]

<[link removed]>
National Institute on Aging — memory, forgetfulness and when to see a doctor —
[link removed]

<[link removed]>
National Institute on Aging — assessing cognitive impairment in older patients
—
[link removed]

<[link removed]>
National Institute of Neurological Disorders and Stroke — delirium and acute
confusional states —[link removed]
<[link removed]>
U.S. Food and Drug Administration — benzodiazepines, boxed warning and risks
in older adults —
[link removed]

<[link removed]>
Agency for Healthcare Research and Quality — medication review and
deprescribing resources —
[link removed]
<[link removed]> Connor
Hill · InsightfulWord



You’re receiving this email from Insightful Word (IW), a brand of TerraTrance
Technologies, LLC.

Mailing address: 200 Broadway Blvd NE
Albuquerque, NM 87102



Need help or have a question? Simply reply to this message or email us at
[email protected] <mailto:[email protected]>



Please note: the content of this email is protected and may not be copied,
forwarded, or distributed without written consent from TerraTrance
Technologies, LLC.



Privacy Policy <[link removed]>
Terms & Conditions <[link removed]>
Unsubscribe
<[link removed]>



© 2026 Insightful Word (IW). All Rights Reserved.